Healthcare

Smart Biopsy Devices Market Trends, Segments, Demand 2024-2033 | Cardinal Health Inc., General Electric Company, Medtronic PLC, Danaher Corporation, Canon Medical Systems Corporation

Senior chemist analysing blood sample while coworkers discussing in background about vaccine development working overtime in chemistry equipped laboratory.

The Smart Biopsy Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Smart Biopsy Devices Market:

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

According to The Business Research Company’s Smart Biopsy Devices Global Market Report 2024, The smart biopsy devices market size has grown strongly in recent years. It will grow from $2.73 billion in 2023 to $2.93 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increased cancer cases, demand for minimally invasive procedures, innovations in medical devices, improved diagnostic accuracy.

The smart biopsy devices market size is expected to see strong growth in the next few years. It will grow to $3.78 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to personalized medicine growth, advancements in imaging modalities, rise in biopsy for biomarker analysis, market entry of new players, enhanced data connectivity. Major trends in the forecast period include robot-assisted biopsies, ai-driven biopsy assistance, development of wireless biopsy tools, portable and handheld devices, real-time guidance systems.

The rising cancer cases are expected to propel the growth of the smart biopsy devices market going forward. Cancer is a broad category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. The rising number of cancer cases increased the need for precise and focused tissue samples. This has sparked the creation and advancement of smart biopsy instruments with better molecular, imaging, and precision capabilities to aid diagnosis and treatment planning. For instance, in October 2022, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2021, 1.58 million new cancer cases were diagnosed in Australia, an increase from 1.54 million new cancer cases in 2020. Therefore, the rising cancer cases are driving the growth of the smart biopsy device market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

The smart biopsy devices market covered in this report is segmented –

1) By Product: Needle-Based Biopsy Instruments, Procedure trays, Localization Wires, Other Products

2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques

3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications

4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Technological innovation has emerged as a key trend gaining popularity in the smart biopsy devices market. Major companies operating in the smart biopsy device market are concentrating on creating innovative products to strengthen their position in the market. For instance, in April 2021, IZI Medical Products LLC, a US-based medical devices company, launched the Quick-Core Auto Biopsy System (Quick-Core Auto Technology) for soft tissue biopsy. It is portable, utterly automatic biopsy equipment that builds on the success of IZI’s semi-automatic Quick-Core biopsy gadget. It provides the same level of dependability, accuracy, and quality. The Quick-Core Biopsy Needle is lightweight and compact, allowing one-handed use during procedures.

The smart biopsy devices market report table of contents includes:

1. Executive Summary

2. Smart Biopsy Devices Market Characteristics

3. Smart Biopsy Devices Market Trends And Strategies

4. Smart Biopsy Devices Market – Macro Economic Scenario

5. Global Smart Biopsy Devices Market Size and Growth

32. Global Smart Biopsy Devices Market Competitive Benchmarking

33. Global Smart Biopsy Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Smart Biopsy Devices Market

35. Smart Biopsy Devices Market Future Outlook and Potential Analysis

36. Appendix

Top Major Players :